Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 1.4 | 2 |
NAV | ₹10.25 | ₹57.57 |
Fund Started | 15 Nov 2021 | 18 Jun 2012 |
Fund Size | ₹46.61 Cr | ₹3019.13 Cr |
Exit Load | Exit load of 0.5%, if redeemed within 90 days. | Exit load of 1% if redeemed within 1 month. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 10.33% | -0.26% |
3 Year | 0.83% | 10.88% |
5 Year | - | 12.38% |
1 Year
3 Year
5 Year
Equity | 0.00% | 98.41% |
Cash | 98.60% | 1.59% |
Equity
Cash
Top 10 Holdings | - |
|
Top 10 Holdings
Name | Assets |
---|---|
Huntington Ingalls Industries Inc. (US) | 3.13% |
West Pharmaceutical Services Inc | 2.98% |
Corteva Inc. | 2.94% |
Zimmer Biomet Holdings | 2.73% |
Brown-Forman Corp | 2.71% |
Veeva Systems Inc. | 2.69% |
Campbell Soup Co. | 2.60% |
The Walt Disney Company | 2.60% |
The Boeing Co | 2.59% |
Monolithic Power Systems Inc. | 2.45% |
Name | Vivek Sharma | Ritesh Lunawat |
Start Date | 15 Feb 2025 | 28 Dec 2020 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation from investing in the units of PGIM Global Select Real Estate Securities Fund, which primarily invests in REITs and equity and equity related securities of real estate companies located throughout the world. | The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies. |
Launch Date | 15 Nov 2021 | 18 Jun 2012 |
Description
Launch Date